Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study

BACKGROUND: Capecitabine plus cisplatin (XP) is recognized as one of the global standard first-line chemotherapy regimens for patients with metastatic gastric cancer (mGC). Recent multinational phase III trials in mGC have been conducted with XP as the control arm, although no data on XP in Japanese...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yamaguchi, Kensei, Sawaki, Akira, Doi, Toshihiko, Satoh, Taroh, Yamada, Yasuhide, Omuro, Yasushi, Nishina, Tomohiro, Boku, Narikazu, Chin, Keisho, Hamamoto, Yasuo, Takiuchi, Hiroya, Komatsu, Yoshito, Saji, Shigehira, Koizumi, Wasaburo, Miyata, Yoshinori, Sato, Atsushi, Baba, Eishi, Tamura, Takao, Abe, Takashi, Ohtsu, Atsushi
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Japan 2012
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3627028/
https://ncbi.nlm.nih.gov/pubmed/22782463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-012-0167-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados